Real-time enrollment status for this t-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:14 PM UTC
| NCT Number | NCT07356245 |
| Recruiting Status | Recruiting |
| Condition | T-cell Lymphoma |
| Phase | PHASE2 |
| Target Enrollment | 44 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Jonathan Brammer |
| Last Updated on CT.gov | April 15, 2026 (Apr 15, 2026) |
As of July 17, 2026: Clinical trial NCT07356245 is currently recruiting participants. This phase2 study for t-cell lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Jonathan Brammer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07356245 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07356245 was last updated Apr 15, 2026 (April 15, 2026). HelloStudys verifies this status automatically.